Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Severity of Lesions Assessed by FFR in Coronary Disease: Is It Associated with Major Events?

severity of lesions ffrIn patients with coronary disease, the prognosis depends on the extent and reversibility of myocardial ischemia. Whether the outcome also depends on the severity of stenosis as determined by fractional flow reserve (FFR) has not been studied yet.

 

This study investigates the relationship between fractional flow reserve values and vessel-related events. Major adverse cardiovascular events (MACE) at 2 years were prospectively studied in 607 patients in whom all stenoses were assessed by FFR and who received medical therapy only.

 

Moreover, logistic regression models were used to calculate the decrease in the risk per 0.05 increase in FFR values.

 

Events were present for 272 (26.5%) of 1029 lesions. Lesions with stenosis diameter ≥70% were more often present in the group experiencing events (p <0.01).

 

The mean fractional flow reserve value was significantly lower in the group experiencing events than in the group with no events (0.68 vs. 0.80; p <0.01).

 

The cumulative incidence of MACE significantly increases with increasing FFR quartiles.

 

The average decrease in MACE per 0.05 increase in FFR was statistically significant, even after adjustment for all clinical and angiographic variables. The strongest increase in adverse events occurred for FFR values between 0.80 and 0.60. In a multivariate analysis, FFR was significantly associated with events at 2 years

 

Conclusion

In patients with stable coronary disease, functional severity of a lesion as assessed by fractional flow reserve is independently associated with major cardiovascular events.

 

Original title: A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.

Reference: Emanuele Barbato et al. J Am Coll Cardiol. 2016;68(21):2247-2255.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...